R&D Projects

CoVIg3

Rapid diagnostic kit for coronavirus immunization

The CoVIg3 project aims to develop a point-of-care rapid test based on lateral flow technology for the qualitative detection of antibodies generated by the humoral response in patients exposed to coronavirus (SARS-Cov-2), whether asymptomatic or having contracted the disease with varying levels of severity. The test will simultaneously carry out a multiplexed analysis of IgA, IgM, and IgG immunoglobulins independently in a single device. The test to be developed will have high sensitivity and specificity levels, a fast response time (15 min), and a low cost.

Secondly, the aim is to analyse the genetic profiles of the Human Leukocyte Antigen (HLA) involved in the response to infections in order to find haplotypes with sensitivity/resistance to infection, as well as possible predictors of the evolution of the disease in its varying levels of severity.

15

minutes are enough for the test to diagnose SARS-Cov-2

detailGrey

CoVIg3 develops a rapid test for the detection of the coronavirus and studies the immunisation process.

Lastly, the project aims to study the immunisation process of patients suspected of having or diagnosed with COVID-19 by analysing the humoral response of IgA, IgM and IgG immunoglobulins, targeting a highly exposed population of enormous strategic value in the fight against the pandemic, healthcare workers.

To achieve the objectives

2020-2021

To achieve the objectives set in the project, Atrys Health collaborates with the Vithas Group. The project is co-funded by the Centre for the Development of Industrial Technology (CDTI) and the European Regional Development Fund (ERDF).

Financial backers

Related projects

eHealth

eHealth

Creación de espacios eHealth en hoteles mediante el desarrollo de una plataforma de telemedicina

Read more
InmunoSIGHT

InmunoSIGHT

Caracterización inmunológica y molecular de pacientes de cáncer de pulmón para inmunoterapia

Read more
iDoctus-Hacking ético

iDoctus-Hacking ético

Plataforma para la detección de enfermedades infecciosas mediante big data y hacking ético

Read more
GLIOMATHERAPY

GLIOMATHERAPY

Inmunoterapia con un anticuerpo monoclonal frente a tumores cerebrales de alto grado

Read more